Stock TVTX TRAVERE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Travere Therapeutics, Inc.

Equities

TVTX

US89422G1076

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-05-17 pm EDT 		5-day change 1st Jan Change
6.06 USD -9.42% Intraday chart for Travere Therapeutics, Inc. -3.81% -32.59%
May. 15 Transcript : Travere Therapeutics, Inc. Presents at Bank of America Health Care Conference 2024, May-15-2024 08:00 AM
May. 07 Canaccord Genuity Adjusts Price Target on Travere Therapeutics to $18 From $15, Maintains Buy Rating MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
TRAVERE THERAPEUTICS, INC. Stock Travere Therapeutics, Inc.
 461M -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 115B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 106B
ARGENX SE Stock argenx SE
 21.96B -
BIONTECH SE Stock BioNTech SE
 21.84B -
GENMAB A/S Stock Genmab A/S
 19.21B
  1. Stock Market
  2. Equities
  3. TVTX Stock
  4. Charts Travere Therapeutics, Inc.
  5. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW